SCOTTSDALE, Ariz. & LOS ANGELES--(BUSINESS WIRE)-- Makucell, Inc., a life science company dedicated to the development, manufacture and distribution of non-prescriptive topical products formulated to address the challenges of aging skin, today announces the appointment of Kevin J. Scanlon, Ph.D., to its Board of Advisors. Dr. Scanlon’s multifaceted career includes three start-up companies, pharmaceutical industry senior management and academic medicine. He is the founder and current CEO of International BioScience, (www.internationalbioscience.com) a company organized to integrate the creative knowledge of science with the core disciplines and strategies of business development to advance the diagnosis and treatment of human disease. Dr. Scanlon has worked with the governments of Ireland, China and New Zealand to create innovation based upon intellectual property at universities in these countries. At the UCLA Anderson School of Management, he is a faculty advisor in the FEMBA Global Access Program, expanding students’ understanding of the life science industry. Dr. Scanlon is the Chairman of the Pasadena Angels Investment Group and is an executive member of the Los Angeles Network of the Tech Coast Angels.
